Orion Pharma Limited (DSE: ORIONPHARM)

Market Cap	8.12B
Revenue (ttm)	8.66B
Net Income (ttm)	196.78M
Shares Out	234.00M
EPS (ttm)	0.84
PE Ratio	41.26
Forward PE	n/a
Dividend	1.00 (2.87%)
Ex-Dividend Date	Dec 5, 2024

Volume	1,393,776
Average Volume	853,728
Open	34.80
Previous Close	34.80
Day's Range	34.40 - 35.60
52-Week Range	30.90 - 91.80
Beta	-0.60
RSI	40.51
Earnings Date	Jan 29, 2025

About Orion Pharma

Orion Pharma Limited engages in the creation, discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. The company produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups, such as anticancer, antibiotics, anti-diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. It also provides various vaccines and health-related consumer products, as well as generates and supplies electricity. The c...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 3,160
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONPHARM

Financial Performance

In 2024, Orion Pharma's revenue was 10.62 billion, a decrease of -23.74% compared to the previous year's 13.93 billion. Earnings were 318.12 million, a decrease of -50.37%.